1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: There was no share repurchase activity for the company's third quarter of 2022.
−Removed: On September 23, 2021, the Board of Directors authorized the repurchase of up to $3.00 billion of the company’s common stock.
−Removed: In the fourth quarter of 2022, the company repurchased $1.00 billion of the company’s common stock (2.0 million shares), depleting the 2021 authorization.
+Added: A summary of the share repurchase activity for the company’s first quarter of 2023 follows:
+Added: Period Total number of shares purchased Average price paid per share (1) Total number of shares purchased as part of publicly announced plans or programs (2) Maximum dollar amount of shares that may yet be purchased under the plans or programs (1)(2)
+Added: (in millions)
+Added: Fiscal January (Jan.
+Added: 4) 5,222,234 $ 574.47 5,222,234 $ 1,000
+Added: Fiscal February (Feb.
+Added: 4) — — — 1,000
+Added: Fiscal March (Mar.
+Added: 1) — — — 1,000
+Added: Total first quarter 5,222,234 $ 574.47 5,222,234 $ 1,000
+Added: (1) Amounts exclude excise taxes and other transaction costs.
+Added: (2) On November 10, 2022, the Board of Directors authorized the repurchase of up to $4.00 billion of the company’s common stock.
+Added: All of the shares of common stock repurchased by the company during the first quarter of 2023 were under this program.
+Added: THERMO FISHER SCIENTIFIC INC.
Number Description of Exhibit
+Added: 10.1 Form of Thermo Fisher Scientific Inc.’s Performance Restricted Stock Unit Agreement effective as of February 22, 2023 *
+Added: 10.2 Form of Thermo Fisher Scientific Inc.’s Restricted Stock Unit Agreement effective as of February 22, 2023 *
+Added: 10.3 Form of Thermo Fisher Scientific Inc.’s Nonstatutory Stock Option Agreement effective as of February 22, 2023 *
+Added: 10.4 Form of Thermo Fisher Scientific Inc.’s Performance Restricted Stock Unit Agreement between Thermo Fisher Scientific Inc.
+Added: Casper effective as of February 22, 2023 *
+Added: 10.5 Form of Thermo Fisher Scientific Inc.’s Restricted Stock Unit Agreement between Thermo Fisher Scientific Inc.
+Added: Casper effective as of February 22, 2023 *
+Added: 10.6 Form of Thermo Fisher Scientific Inc.’s Nonstatutory Stock Option Agreement between Thermo Fisher Scientific Inc.
+Added: Casper effective as of February 22, 2023 *
+Added: 10.7 Form of Executive Change in Control Retention Agreement for Officers (other than Marc N.
31.1 Certification of Chief Executive Officer required by Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
11 unchanged sentences
_______________________
+Added: * Indicates management contract or compensatory plan, contract or arrangement.
** Certification is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section.
1 unchanged sentence
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: November 4, 2022 THERMO FISHER SCIENTIFIC INC.
+Added: May 5, 2023 THERMO FISHER SCIENTIFIC INC.
/s/ Stephen Williamson
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.